The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| XENON PHARMACEUTICALS, INC. | Common Stock | 98420N105 | 808 | 79,539 | SH | DFND | IPC | 79,539 | 0 | 0 | |
| Navigator Holdings Ltd. | Common Stock | Y62132108 | 240,503 | 21,863,874 | SH | DFND | WL Ross | 21,863,874 | 0 | 0 | |
| Amalgamated Bank | Common Stock | 022663108 | 23,515 | 1,502,582 | SH | DFND | WL Ross | 1,502,582 | 0 | 0 | |
| Diamond S Shipping Inc. | Common Stock | Y20676105 | 100,881 | 9,700,130 | SH | DFND | WL Ross | 9,700,130 | 0 | 0 | |